117 related articles for article (PubMed ID: 11803395)
21. The terminal repeats and latency-associated nuclear antigen of herpesvirus saimiri are essential for episomal persistence of the viral genome.
Collins CM; Medveczky MM; Lund T; Medveczky PG
J Gen Virol; 2002 Sep; 83(Pt 9):2269-2278. PubMed ID: 12185282
[TBL] [Abstract][Full Text] [Related]
22. Open reading frame 73 is required for herpesvirus saimiri A11-S4 episomal persistence.
Calderwood M; White RE; Griffiths RA; Whitehouse A
J Gen Virol; 2005 Oct; 86(Pt 10):2703-2708. PubMed ID: 16186223
[TBL] [Abstract][Full Text] [Related]
23. Gene transfer into human hematopoietic progenitor cells with an episomal vector carrying an S/MAR element.
Papapetrou EP; Ziros PG; Micheva ID; Zoumbos NC; Athanassiadou A
Gene Ther; 2006 Jan; 13(1):40-51. PubMed ID: 16094410
[TBL] [Abstract][Full Text] [Related]
24. Efficient lentiviral transduction of Herpesvirus saimiri immortalized T cells as a model for gene therapy in primary immunodeficiencies.
Toscano MG; Frecha C; Ortega C; Santamaría M; Martín F; Molina IJ
Gene Ther; 2004 Jun; 11(12):956-61. PubMed ID: 15029233
[TBL] [Abstract][Full Text] [Related]
25. Stable marker gene transfer into human bone marrow stromal cells and their progenitors using novel herpesvirus saimiri-based vectors.
Frolova-Jones EA; Ensser A; Stevenson AJ; Kinsey SE; Meredith DM
J Hematother Stem Cell Res; 2000 Aug; 9(4):573-81. PubMed ID: 10982258
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of Tet-on system to avoid transgene down-regulation in ex vivo gene transfer to the CNS.
Johansen J; Rosenblad C; Andsberg K; Møller A; Lundberg C; Björlund A; Johansen TE
Gene Ther; 2002 Oct; 9(19):1291-301. PubMed ID: 12224012
[TBL] [Abstract][Full Text] [Related]
27. Tumor-specific intravenous gene delivery using oncolytic adenoviruses.
Zhan J; Gao Y; Wang W; Shen A; Aspelund A; Young M; Laquerre S; Post L; Shen Y
Cancer Gene Ther; 2005 Jan; 12(1):19-25. PubMed ID: 15514685
[TBL] [Abstract][Full Text] [Related]
28. Enhanced in vivo transgene expression and immunogenicity from plasmid vectors following electrostimulation in rodents and primates.
Simon AJ; Casimiro DR; Finnefrock AC; Davies ME; Tang A; Chen M; Chastain M; Kath GS; Chen L; Shiver JW
Vaccine; 2008 Sep; 26(40):5202-9. PubMed ID: 18472195
[TBL] [Abstract][Full Text] [Related]
29. Characterization of a semi-replicative gene delivery system allowing propagation of complementary defective retroviral vectors.
Trajcevski S; Solly SK; Frisén C; Trenado A; Cosset FL; Klatzmann D
J Gene Med; 2005 Mar; 7(3):276-87. PubMed ID: 15515136
[TBL] [Abstract][Full Text] [Related]
30. Histone modification pattern of the T-cellular Herpesvirus saimiri genome in latency.
Alberter B; Ensser A
J Virol; 2007 Mar; 81(5):2524-30. PubMed ID: 17151105
[TBL] [Abstract][Full Text] [Related]
31. Characterization of the herpesvirus saimiri ORF73 gene product.
Hall KT; Giles MS; Goodwin DJ; Calderwood MA; Markham AF; Whitehouse A
J Gen Virol; 2000 Nov; 81(Pt 11):2653-2658. PubMed ID: 11038376
[TBL] [Abstract][Full Text] [Related]
32. Stable correction of a genetic deficiency in human cells by an episome carrying a 115 kb genomic transgene.
Wade-Martins R; White RE; Kimura H; Cook PR; James MR
Nat Biotechnol; 2000 Dec; 18(12):1311-4. PubMed ID: 11101814
[TBL] [Abstract][Full Text] [Related]
33. Mutation of herpesvirus Saimiri ORF51 glycoprotein specifically targets infectivity to hepatocellular carcinoma cell lines.
Turrell SJ; Whitehouse A
J Biomed Biotechnol; 2011; 2011():785158. PubMed ID: 21197456
[TBL] [Abstract][Full Text] [Related]
34. Transduction of Herpesvirus saimiri-Transformed T Cells with Exogenous Genes of Interest.
Martínez-Barricarte R; de Jong SJ; Markle J; de Paus R; Boisson-Dupuis S; Bustamante J; van de Vosse E; Fleckenstein B; Casanova JL
Curr Protoc Immunol; 2016 Nov; 115():7.21C.1-7.21C.12. PubMed ID: 27801513
[TBL] [Abstract][Full Text] [Related]
35. Analysis of gene expression in a human cell line stably transduced with herpesvirus saimiri.
Hall KT; Giles MS; Goodwin DJ; Calderwood MA; Carr IM; Stevenson AJ; Markham AF; Whitehouse A
J Virol; 2000 Aug; 74(16):7331-7. PubMed ID: 10906186
[TBL] [Abstract][Full Text] [Related]
36. Peripheral T-cell lymphoma in herpesvirus saimiri-infected tamarins: tumor cell lines reveal subgroup-specific differences.
Reiss C; Niedobitek G; Hör S; Lisner R; Friedrich U; Bodemer W; Biesinger B
Virology; 2002 Mar; 294(1):31-46. PubMed ID: 11886263
[TBL] [Abstract][Full Text] [Related]
37. A transfectant mosaic xenograft model for evaluation of targeted radiotherapy in combination with gene therapy in vivo.
Mairs RJ; Ross SC; McCluskey AG; Boyd M
J Nucl Med; 2007 Sep; 48(9):1519-26. PubMed ID: 17704246
[TBL] [Abstract][Full Text] [Related]
38. Recombinant adeno-associated virus mediated RNA interference inhibits metastasis of nasopharyngeal cancer cells in vivo and in vitro by suppression of Epstein-Barr virus encoded LMP-1.
Li X; Liu X; Li CY; Ding Y; Chau D; Li G; Kung HF; Lin MC; Peng Y
Int J Oncol; 2006 Sep; 29(3):595-603. PubMed ID: 16865275
[TBL] [Abstract][Full Text] [Related]
39. Sustained transgene expression by human cord blood derived CD34+ cells transduced with simian immunodeficiency virus agmTYO1-based vectors carrying the human coagulation factor VIII gene in NOD/SCID mice.
Kikuchi J; Mimuro J; Ogata K; Tabata T; Ueda Y; Ishiwata A; Kimura K; Takano K; Madoiwa S; Mizukami H; Hanazono Y; Kume A; Hasegawa M; Ozawa K; Sakata Y
J Gene Med; 2004 Oct; 6(10):1049-60. PubMed ID: 15386735
[TBL] [Abstract][Full Text] [Related]
40. Lentiviral vectors transcriptionally targeted to hematopoietic cells by WASP gene proximal promoter sequences.
Martín F; Toscano MG; Blundell M; Frecha C; Srivastava GK; Santamaría M; Thrasher AJ; Molina IJ
Gene Ther; 2005 Apr; 12(8):715-23. PubMed ID: 15750617
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
